Navigation Links
Affymetrix and Stratagene Announce Strategic Software Alliance

Affymetrix and Stratagene announced today that they have entered into a non-exclusive strategic alliance under which Stratagene will provide Affymetrix customers with new software solutions for GeneChip(R) data analysis. As part of this agreement, Stratagene will develop a new software package for Affymetrix, ArrayAssist(R) Lite, which will be offered as a standard statistical analysis solution of Affymetrix gene expression microarrays.

In April 2005, Affymetrix will make ArrayAssist Lite available to its existing GeneChip customers via the Internet and will also begin pre-installing the software on new GeneChip workstation desktops. Through an easy-to-use interface and tightly integrated workflow, ArrayAssist Lite will enable the application of industry-leading statistical algorithms and generation of standard Affymetrix-format data files and reports. In its first release, ArrayAssist Lite will support RMA, GC-RMA, MAS5, and also PLIER, a new advanced signal estimator developed by Affymetrix statisticians. Affymetrix customers will also be given the option of upgrading to Stratagene's ArrayAssist software, which provides advanced downstream analysis capabilities such as gene clustering, pattern detection, and interactive visualizations.

"ArrayAssist Lite software will provide highly accurate, precise and sensitive methods needed to support expression research," said Jason Goncalves, General Manager of Stratagene's software solutions business. "We've placed these capabilities in a software tool designed for life scientists, and the result will be better quality data to accelerate biological discovery and validation."

"We are very pleased to announce this expansion of our longstanding relationship with Stratagene," said Steve Lincoln, Vice-President of Informatics at Affymetrix. "The combination of our GeneChip platform and the ArrayAssist softw are makes the industry-leading methods for measuring gene expression on a genomic-scale available to an ever broadening community of life scientists."

As part of the agreement, Stratagene has joined the community of Affymetrix partners developing methods for next-generation gene expression microarrays. "Affymetrix' tiling arrays are revolutionizing functional analysis," said Dr. Joseph A. Sorge, Chairman and CEO of Stratagene. "We believe that our technology will provide key functionality needed to support important genomic studies. In addition, we're very excited to join Affymetrix' consortium of developers in an effort to bring to market breakthrough gene expression microarray technology. By partnering with other thought leaders in our field, we believe we have the opportunity to position our technology as a standard for expression analysis."


'"/>

Source:Affymetrix


Related biology news :

1. Affymetrix Unveils Plans to Double Plant and Animal Genome Microarray Offering
2. New Study from Affymetrix Laboratories Points to Changing View of How Genome Works
3. Affymetrix and the Karolinska Institutet Announce Translational Medicine Strategic Alliance
4. Affymetrix Licenses Microfluidics Technology From Caliper Life Sciences
5. Affymetrix Launches New Globin-Reduction Kits and Protocol Developed with PreAnalytiX
6. Affymetrix and bioMerieux Extend Their Agreement on GeneChip(R) Technology to Breast Cancer Diagnostics
7. Affymetrix and ParAllele Launch Industrys Most Comprehensive Product Line for Targeted Genotyping
8. Genomatix Microarray Analysis Pipeline achieves Affymetrix GeneChip compatible?status
9. Affymetrix 500K array used to identify memory gene
10. FDA Announces Series of Changes to the Class of Marketed Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
11. Ariadne Genomics Announces the Release of PathwayStudio?Central, Client-Server Software for Biological Pathway Analysis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/11/2017)... , April 11, 2017 Crossmatch®, a ... authentication solutions, today announced that it has been ... Research Projects Activity (IARPA) to develop next-generation Presentation ... "Innovation has been a driving force ... program will allow us to innovate and develop ...
(Date:4/6/2017)... , April 6, 2017 ... RFID, ANPR, Document Readers, by End-Use (Transportation & Logistics, ... Facility, Oil, Gas & Fossil Generation Facility, Nuclear Power), ... Educational, Other) Are you looking for a ... sector? ...
(Date:4/4/2017)... --  EyeLock LLC , a leader of iris-based identity ... and Trademark Office (USPTO) has issued U.S. Patent No. ... iris image with a face image acquired in sequence ... th issued patent. "The issuance ... multi-modal biometric capabilities that have recently come to market ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology ... drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription ... is able to cross the cell membrane and bind intracellular STAT3 and inhibit ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give it ... Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder and CEO of ... Rotary Club. The event entitled “Stem Cells and Their Regenerative Powers,” ... Dr. Harman, DVM, MPVM was joined by two human doctors: Peter B. Hanson, ...
(Date:10/10/2017)... Oct. 10, 2017 SomaGenics announced the receipt ... to develop RealSeq®-SC (Single Cell), expected to be the ... RNAs (including microRNAs) from single cells using NGS methods. ... need to accelerate development of approaches to analyze the ... "New techniques for measuring levels of mRNAs in ...
Breaking Biology Technology: